U.S. Food and Drug Administration advisers unanimously recommended on Thursday that COVID-19 vaccines for the 2025-26 period ...

The FDA is implementing stricter guidance for the approval of COVID-19 vaccines, according to a paper published in The New England Journal of Medicine.

It may not be the mythical fountain of youth, but the strength of the body's immune system, or immune resilience, could hold ...

A report released Thursday said highly processed foods, exposure to chemicals and excessive use of prescription drugs are ...

The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to ...

An FDA advisory committee unanimously recommended Thursday that the next COVID vaccine should be a monovalent one in the JN.1 ...

Advisers to the Food and Drug Administration met Thursday to help decide which variant of the virus that causes COVID should ...

Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter ...

The Food and Drug Administration (FDA) vaccine advisory group today recommended sticking with a monovalent JN.1 lineage ...

Government advisers are convening to discuss potential COVID-19 vaccine updates for the fall and winter, amidst a new policy that limits routine boosters to seniors and high-risk individuals. The FDA ...

The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels about heart inflammation.